Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

119 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Denileukin diftitox for the treatment of steroid-resistant acute graft-versus-host disease.
Shaughnessy PJ, Bachier C, Grimley M, Freytes CO, Callander NS, Essell JH, Flomenberg N, Selby G, Lemaistre CF. Shaughnessy PJ, et al. Among authors: lemaistre cf. Biol Blood Marrow Transplant. 2005 Mar;11(3):188-93. doi: 10.1016/j.bbmt.2004.11.022. Biol Blood Marrow Transplant. 2005. PMID: 15744237 Free article. Clinical Trial.
Phase II study of a moderate-intensity preparative regimen with allogeneic peripheral blood stem cell transplantation for hematologic diseases: the Texas Transplant Consortium experience.
Shaughnessy PJ, Ornstein D, Ririe D, Callander N, Anderson JE, Pollack MS, Freytes CO, Cruz J, Rodriquez T, Bachier C, LeMaistre CF. Shaughnessy PJ, et al. Among authors: lemaistre cf. Biol Blood Marrow Transplant. 2002;8(8):420-8. doi: 10.1053/bbmt.2002.v8.pm12234167. Biol Blood Marrow Transplant. 2002. PMID: 12234167 Free article. Clinical Trial.
High white blood cell concentration in the peripheral blood stem cell product can induce seizures during infusion of autologous peripheral blood stem cells.
Bachier C, Potter J, Potter G, Sugay R, Shaughnessy P, Chan K, Jude V, Madden R, LeMaistre CF. Bachier C, et al. Among authors: lemaistre cf. Biol Blood Marrow Transplant. 2012 Jul;18(7):1055-60. doi: 10.1016/j.bbmt.2011.12.500. Epub 2011 Dec 16. Biol Blood Marrow Transplant. 2012. PMID: 22178402 Free article.
Phase I and pharmacokinetic study of once-daily dosing of intravenously administered busulfan in the setting of a reduced-intensity preparative regimen and allogeneic hematopoietic stem cell transplantation as immunotherapy for renal cell carcinoma.
Shaughnessy P, Alexander W, Tran H, Ririe D, Splichal J, Pollack M, Bachier C, LeMaistre C. Shaughnessy P, et al. Mil Med. 2006 Feb;171(2):161-5. doi: 10.7205/milmed.171.2.161. Mil Med. 2006. PMID: 16578989 Clinical Trial.
Hospital length of stay in the first 100 days after allogeneic hematopoietic cell transplantation for acute leukemia in remission: comparison among alternative graft sources.
Ballen KK, Joffe S, Brazauskas R, Wang Z, Aljurf MD, Akpek G, Dandoy C, Frangoul HA, Freytes CO, Khera N, Lazarus HM, LeMaistre CF, Mehta P, Parsons SK, Szwajcer D, Ustun C, Wood WA, Majhail NS. Ballen KK, et al. Among authors: lemaistre cf. Biol Blood Marrow Transplant. 2014 Nov;20(11):1819-27. doi: 10.1016/j.bbmt.2014.07.021. Epub 2014 Jul 23. Biol Blood Marrow Transplant. 2014. PMID: 25064747 Free PMC article.
Comparison of Characteristics and Outcomes of Trial Participants and Nonparticipants: Example of Blood and Marrow Transplant Clinical Trials Network 0201 Trial.
Khera N, Majhail NS, Brazauskas R, Wang Z, He N, Aljurf MD, Akpek G, Atsuta Y, Beattie S, Bredeson CN, Burns LJ, Dalal JD, Freytes CO, Gupta V, Inamoto Y, Lazarus HM, LeMaistre CF, Steinberg A, Szwajcer D, Wingard JR, Wirk B, Wood WA, Joffe S, Hahn TE, Loberiza FR, Anasetti C, Horowitz MM, Lee SJ. Khera N, et al. Among authors: lemaistre cf. Biol Blood Marrow Transplant. 2015 Oct;21(10):1815-22. doi: 10.1016/j.bbmt.2015.06.004. Epub 2015 Jun 11. Biol Blood Marrow Transplant. 2015. PMID: 26071866 Free PMC article.
119 results